[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1997

Carcinomatous Meningitis

Author Affiliations

Department of Neurosciences University of California, San Diego 9500 Gilman Dr La Jolla, CA 92093

Arch Neurol. 1997;54(1):16-17. doi:10.1001/archneur.1997.00550130008003
Abstract

The article by Balm and Hammack1 in a recent issue of the Archives is a commendable effort and reviews the recent study at the Mayo Clinic, Rochester, Minn. However, the study suffers from being a retrospective analysis and from the lack of a consistent approach to patients with leptomeningeal metastasis (LM).

For example, it is not clear why some patients were treated aggressively (n=52), vs offered no treatment (n=35) or radiation therapy only (n=37). Because their article suggests that aggressive treatment with intracerebrospinal fluid (intra-CSF) chemotherapy plus involved-field central nervous system radiation is associated with a better outcome, I believe it is incumbent on neurooncologists to conduct a randomized prospective study regarding the benefits of aggressive treatment. Several recent studies of the treatment of LM have suggested that administration of systemic chemotherapy plus involved-field central nervous system radiotherapy may be sufficient treatment.2

Furthermore, in the study by Balm

First Page Preview View Large
First page PDF preview
First page PDF preview
×